NCT03156686 (SAFE-HOME) is a NA clinical trial of HOME-based hospitalization in Heart Failure, sponsored by French Cardiology Society.

Who is sponsoring NCT03156686?

NCT03156686 is sponsored by French Cardiology Society.

What drugs are being tested in NCT03156686?

Interventions in NCT03156686: HOME-based hospitalization.

What condition does NCT03156686 study?

NCT03156686 studies Heart Failure.

Is NCT03156686 still recruiting?

NCT03156686 is currently terminated. Last updated 15 February 2023.

Last reviewed 2023-02-15 · How we verify

NCT03156686: SAFE-HOME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SAFEty and Efficacy of HOME-based Hospitalization Versus Inpatient Care for Patients With Acute Heart Failure in Chronic Heart Failure.

Terminated NA Last updated 15 February 2023

What this trial tests

NA trial testing HOME-based hospitalization in Heart Failure in 10 participants. Terminated before completion.

Timeline

1 June 2017

Primary endpoint
29 September 2022

31 December 2022

Quick facts

Lead sponsor	French Cardiology Society
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	1 June 2017
Primary completion	29 September 2022
Estimated completion	31 December 2022
Sites	2 locations across France

Drugs / interventions tested

HOME-based hospitalization

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

French Cardiology Society

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the efficacy, safety and and cost of home care versus conventional hospitalization care at 3-months in patients with worsening chronic heart failure.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Practical outpatient management of worsening chronic heart failure.
Girerd N, Mewton N, Tartière JM, Guijarro D, et al · · 2022 · cited 43× · PMID 35417093 · DOI 10.1002/ejhf.2503
Admission avoidance hospital at home.
Edgar K, Iliffe S, Doll HA, Clarke MJ, et al · · 2024 · cited 32× · PMID 38438116 · DOI 10.1002/14651858.cd007491.pub3

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other French Cardiology Society trials

Trials by the same sponsor.

NCT07462910 — Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation · NA · not yet recruiting
NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
NCT07181317 — WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up · recruiting
NCT07193225 — Microflow3D - Non-invasive Mapping of Coronary Arteries and the Cerebral Vascular Network Using 3D Ultrasound Localizati · NA · not yet recruiting
NCT06833138 — Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillati · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03156686 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by French Cardiology Society
Last refreshed: 15 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03156686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing